Cell line · CVCL_1094
C-33 A
Cancer cell line, Homo sapiens. Human papillomavirus-independent cervical squamous cell carcinoma. 58 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. C-33 A. Cell lines, record CVCL_1094. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1094
On this page
Cell line
As Cellosaurus gives it.
- Name
- C-33 A
- Accession
- CVCL_1094
- RRID
- RRID:CVCL_1094
- Synonyms
- C33A, C33a, C33-A, C-33-A, C-33A, C33
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 66Y
- Category
- Cancer cell line
- Diseases
- Human papillomavirus-independent cervical squamous cell carcinoma (NCIt C180841); Squamous cell carcinoma of the cervix uteri (ORDO Orphanet_213767)
- Derived from
- Uterus, cervix (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers58
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Elevated neutrophil extracellular traps formation driven by the HPV-mediated CXCL8-CXCR1/2-ROS-p21 axis promotes the growth and metastasis of cervical cancer. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Deciphering HPV-Associated Immune Evasion in Cervical Cancer Through Multi-Omics Profiling and Computational Screening. | Anal Cell Pathol (Amst) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| GATA3 Inhibits the Expression of Viral E6/E7 Genes, and Its Expression Is Compromised During HPV-Mediated Cervical Carcinogenesis. | J Med Virol | 2026 | Its Methods give the RRID and name the line | PubMed | |
Dual-specificity phosphatase 14 inhibits the growth of cervical cancer cells by regulating the transforming growth factor-beta-activated kinase 1 and NOD-like receptor pyrin domain containing 3 inflammatory pathways. | J Int Med Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical Cancer. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy. | Neoplasia | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Development of a novel multi-locus Flow-FISH based assay for detection of progressive cervical precancer lesions. | BMC Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Three-subtype Molecular model of Cervical Cancer: Multiple PI3K Pathway inhibitors suppress growth and cooperate with HPV-directed immunotherapy. | medRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. | Cells | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 58
See all 58 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | HOE6V | CVCL_4J71 | Cell lines | |
| Derived from it | HyCyte C-33 A stable cell line for hGALNT2 overexpression | CVCL_F4RW | Cell lines | |
| Derived from it | SK-OV-4 | CVCL_X008 | Has a recorded problem | Cell lines |
| Derived from it | SK-OV-6 | CVCL_A457 | Has a recorded problem | Cell lines |
| From the same person | C-33 B | CVCL_1E27 | Cell lines |
Cell banks8
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRM-HTB-31 | ATCC | |
| ATCC | HTB-31 | ATCC | |
| AddexBio | C0008003/382 | Cellosaurus | |
| BCRC | 60554 | BCRC | |
| BCRJ | 0348 | BCRJ | |
| CCTCC | GDC0144 | Cellosaurus | |
| CLS | 305072 | CLS | |
| ICLC | HTL02004 | ICLC |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1094
GET https://conductscience.org/api/cell-lines/v1/CVCL_1094/papers?page=2